Press release from Companies: CESSATECH ANNOUNCES DKK 18.3 MILLION CAPITAL RAISE THROUGH A 80% GUARANTEED RIGHTS ISSUE TO FINANCE PIVOTAL DEVELOPMENT OF CT001

Press release from Companies: Great progress during Q3 – more to come

Press release from Companies: Cessatech reports successful outcome of pharmacokinetic trial in children of lead candidate

Press release from Companies: Cessatech reports successful outcome of pharmacokinetic trial in children of lead candidate

Press release from Companies: Cessatech reports first patient dosed in pivotal trial of lead product candidate

Press release from Companies: Second quarter report Q2-2022 – green light for the pivotal trial 0205

Press release from Companies: Good things are worth waiting for - welcome to the second half of 2022!

Press release from Companies: Cessatech reports Regulatory Green Light for trial 0205, the pivotal trial for CT001 - first patient expected shortly

Press release from Companies: Cessatech reports last patient dosed in pharmacokinetic trial in children of lead candidate

Press release from Companies: First quarter report Q1-2022 - preparing for the pivotal trial

Press release from Companies: Newsletter #6 - Mar 2022

Press release from Companies: Minutes from the Annual General Meeting in Cessatech A/S